Achievement of Korea s Healthcare Industry. Devices. World s largest market share in ultrasound imaging devices ( 14) Competitiveness

Size: px

Start display at page:

Download "Achievement of Korea s Healthcare Industry. Devices. World s largest market share in ultrasound imaging devices ( 14) Competitiveness"

Jerome Barker
7 years ago
Views:

1 2015 Healthcare

2 Healthcare Korea's healthcare industry is growing thanks to the advancement of the production infrastructure of pharmaceuticals, medical devices and cosmetics, support for healthcare-related companies to enter overseas markets and expansion of research and development. Achievement of Korea s Healthcare Industry Pharmaceuticals World s first biosimilar antibody approved in EU)( 12) Devices World s largest market share in ultrasound imaging devices ( 14) Services Contract concluded to export KRW 70 billion hospital system to Saudi Arabia ( 14) * Source : Ministry of Science, ICT and Future Planning, Ministry of Trade, Industry & Energy, Ministry of Health and Welfare, Ministry of Food and Drug Safety (2014) Industry Overview Status of healthcare industry Market size and export volume of Korean healthcare industry Competitiveness Status of highly skilled human resources in the pharmaceutical and biotech industry R&D investment Korea s in vitro diagnostic medical device (IVDs) market Government Policies and Incentives Government Investment Strategies to become one of the 7 global biotech powerhouses by 2020 Success Case Celltrion Related Organizations and Associations Related associations Industries Healthcare 1

Achievement of Korea s Healthcare Industry Pharmaceuticals World s first biosimilar antibody approved in EU)( 12) Devices World s largest market share in ultrasound imaging devices ( 14) Services

3 Industry Overview Status of healthcare industry Production volume 147, ,919 No. of companies No. of employees 81,204 88,545 Export and import volume 51,558 23,185-28,373 Medicine Imports Exports Trading balance Production volume No. of companies No. of employees Export and import volume 28,167 38,074 27,643 42,242 2,607 1,754 29,882 25,809-4,073 Medical devices Imports Exports Trading balance Production volume No. of companies No. of employees Export and import volume 79,721 51, ,535 48,426 10,643 14,122 23,629 3,479 Cosmetics Imports Exports Trading balance Production volume No. of companies No. of employees Export and import volume 232, ,782 99,333 25, , ,697 17,341 41,128-58,205 Food Imports Exports Trading balance * Source : 2014 Korea Health Industry White Book Industries Healthcare 2

of employees Export and import volume 28,167 38,074 27,643 42,242 2,607 1,754 29,882 25,809-4,073 Medical devices Imports Exports Trading balance Production volume No. of companies No.

4 Market size and export volume of Korean healthcare industry Market size (Unit: KRW 1 million) Medical devices Cosmetics Medicine 17,970,026 18,908,439 18,943,812 18,580,003 19,029,152 5,534,191 6,303,416 6,589,797 7,022,077 7,624,109 3,644,047 3,902,720 4,306,387 4,592,314 4,632, Export volume (Unit: KRW 1 million) Medical devices Cosmetics Medicine 2,580,862 2,309,534 1,772,242 1,770,059 1,943,493 2,216,074 2,318,522 1,519,027 1,681,619 1,853,785 1,202,383 1,412, , , , * Source: MW (2015) Competitiveness Status of highly skilled human resources in the pharmaceutical and biotech industry Research workforce breakdown by educational background of pharmaceutical industry Others 107 PhD 637 (Unit : people) Research workforce breakdown by educational background of biotech industry Others 1,285 PhD 2,096 (Unit : people) Bachelor's degree 1,509 Master's degree 3,184 Bachelor's degree 15,420 Master's degree 7,411 * Source: Korea Health Industry Development Institute (2014) Analysis report of pharmaceutical industry in * Source: Survey of bio industry (2014) Industries Healthcare 3

1,772,242 1,770,059 1,943,493 2,216,074 2,318,522 1,519,027 1,681,619 1,853,785 1,202,383 1,412,219 530,985 690,211 891,478 2010 2011 * Source: MW (2015) Competitiveness Status of highly skilled

5 R&D investment Korean pharmaceutical companies made research and development (R&D) investments worth KRW billion in. The R&D investment posted a high CAGR of 13.7% over the past five years, reflecting a growing commitment to R&D. The size of private investment in the field of biotech industry in Korea ranks fifth in the world following the United States, France, Japan, and Germany. The size of government or public investment is the second-largest after Germany among all the OECD member countries. 578, R&D investments by Korean pharmaceutical companies 648, , , Korea s biotech R&D investments (Unit : KRW 1 million) 967,239 * Source: Korea Health Industry Statistics System (KHISS) (Unit : KRW 100 million) 11,651 9,302 10, * Source: Biotech Industry Study (2014) Korea s in vitro diagnostic medical device (IVDs) market (Unit : KRW 100 million) 4,174 The in vitro diagnostic segment is expected to be among the fast-growing markets of the biotech industry. The segment has strong growth potential thanks to new technology development and a rapidly aging population. 2, , * Source : Ministry of Trade, Industry & Energy, Five-year Plan for Technology Innovation () Industries Healthcare 4

The size of private investment in the field of biotech industry in Korea ranks fifth in the world following the United States, France, Japan, and Germany.

6 Technology gap between Korea and advanced countries in the biotech sector Korea is one of the leading countries in the bio sector. Fusion medical device Stem cell treatment Gene therapy (Science technology 4.7 years, BT 5 years) 1.8 year 2.8 year 3.8 year * Source: MSIP, MOTIE, MW, Korea Food & Drug Administration (2014) Government Policies and Incentives Government Investment others 38.09% CT 0.95% ET 15.06% BT 18.22% ST 4.75% NT 4.51% IT 18.41% Health care/ Medical treatment: 44.73% Basic research: 28.76% Agriculture/ Environment: 26.49% Government s investment in BT sector USD 2.5 billion 5 strategies Foster strong sectors Promote R&D commercialization Enter new markets Create lifecycle infrastructure Nurture human resources with comprehensive skills * Source : KISTEP, 2015 Industries Healthcare 5

8 year * Source: MSIP, MOTIE, MW, Korea Food & Drug Administration (2014) Government Policies and Incentives Government Investment others 38.09% CT 0.95% ET 15.06% BT 18.22% ST 4.75% NT 4.51% IT 18.

7 Strategies to become one of the 7 global biotech powerhouses by 2020 PHARMA2020 World s TOP 7 Supports R&D businesses through the certification of innovative pharmaceutical company" (`13~) Supports development and commercialization Stem cell research / brain disease research / genome project Tax incentives, research projects funding, and lower medical fees Foster CRO (Contract Research Organization), vitalize CMO (Contract Manufacturing Organization), and expand partnerships and M&A Supports clinical trials, licensing and approvals, and basic research process Korea Drug Development Fund (KDDF): R&D matching fund (USD 1,000 mn, `11-`20) National Onco Venture (NOV) : R&D matching fund (USD 240 mn, `11-`16) Global Pharmaceutical Fund: Policy fund (PEF) (USD 550 mn, `14-`22) Success Case Celltrion Celltrion has attracted KRW 350 billion of investment from a Singaporean government fund, Temasek, since 2010, based on its biosimilar technology and excellent CMO business. Biosimilar technology Excellent CMO business Celltrion Attracted KRW 350 billion of Temasek Singapore Government Fund Industries Healthcare 6

Organization), vitalize CMO (Contract Manufacturing Organization), and expand partnerships and M&A Supports clinical trials, licensing and approvals, and basic research process Korea Drug Development

8 Related Organizations and Associations Related associations Association Website Korea Biomaterial Packaging Association Korean Association of Geriatric Hospitals Korean Hospital Association Korea Pharmaceutical Association Korean Medical Association Korea Ubiquitous-Health Association Korea Biotechnology Industry Association Korea Drug Research Association Korea Medical Devices Industrial Coop. Association Korea Medical Devices Industry Association Korea Pharmaceutical Distribution Association Korea Pharmaceutical Traders Association Korea Pharmaceutical Manufacturers Association Korea Animal Health Product Association Industries Healthcare 7

koreabio.org Korea Drug Research Association www.kdra.or.kr Korea Medical Devices Industrial Coop. Association www.medinet.or.kr Korea Medical Devices Industry Association www.kmdia.or.kr Korea Pharmaceutical Distribution Association www.

GCC Pharmaceutical Industry

GCC Pharmaceutical Industry First coordination meeting for the pharmaceutical industry in the GCC and Yemen Dr. Aasim Qureshi 11 April 2011 Global Pharmaceuticals Industry The pharmaceutical industry is